Qing Hua Chang Yin ameliorates chronic colitis in mice by inhibiting PERK-ATF4-CHOP pathway of ER stress and the NF-κB signalling pathway

• Main Authors: Liya Liu (Author), Youqin Chen (Author), Yuying Han (Author), Xinran Zhang (Author), Yulun Wu (Author), Jing Lin (Author), Liujing Cao (Author), Meizhu Wu (Author), Huifang Zheng (Author), Yi Fang (Author), Lihui Wei (Author), Thomas J. Sferra (Author), Anjum Jafri (Author), Xiao Ke (Author), Jun Peng (Author), Aling Shen (Author)
• Format: Book
• Published: Taylor & Francis Group, 2024-12-01T00:00:00Z.
• Subjects: article
• Online Access: Connect to this object online.

Context Ulcerative colitis has been clinically treated with Qing Hua Chang Yin (QHCY), a traditional Chinese medicine formula. However, its precise mechanisms in mitigating chronic colitis are largely uncharted.Objective To elucidate the therapeutic efficiency of QHCY on chronic colitis and explore...